Edward T.A. Fry, MD, president of the American College of Cardiology and a veteran cardiologist, shared his perspective on the many ways cardiologists can work to limit medical misinformation and disinformation. 

A wave of infections across the United States has led to a run on certain over-the-counter medications, and some retailers are limiting purchases to deal with the seasonal demand.

Described as “disastrous” and “ominous,” the proposed cuts have been subject to rampant industry-wide backlash, with some cautioning that, if enacted, the reductions could cause “immediate financial instability” in the Medicare physician payment system. 

Claire Ernst, director of government affairs, Medical Group Management Association (MGMA), explains the list of priorities for the association, include staving off the large Medicare reimbursement cuts, continuation of telehealth reimbursements, and revamping prior authorizations. 

Prior to the Dec. 15 announcement, CMS had released a different statement in June informing the public that they were reconsidering the amount of PET scans that Alzheimer’s patients undergoing monoclonal antibody treatment can receive.

A recent analysis found that a significant amount of studies do not provide information pertaining to their raw data, source code or model. As a result, up to 97% of these studies do not produce systems that are fit to be used in real-world clinical scenarios. 

A diabetes treatment drug, Mounjaro, has been added to the Food and Drug Administration’s (FDA) list of drug shortages.

Prior to 2018, it was recommended that women at higher-than-average risk undergo supplemental breast MRI screening only if they had a personal history of breast cancer in addition to carrying a hereditary breast cancer gene mutation.